Abacavir, dolutegravir, and lamivudine and Arcapta Neohaler
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Arcapta Neohaler and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: indacaterol
Brand name: Arcapta Neohaler
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Ardeparin Subcutaneous
- Abacavir, dolutegravir, and lamivudine-Aredia
- Abacavir, dolutegravir, and lamivudine-Arestin
- Abacavir, dolutegravir, and lamivudine-Arestin eent
- Abacavir, dolutegravir, and lamivudine-Arestin mucous membrane powder
- Abacavir, dolutegravir, and lamivudine-Arformoterol
- Arcapta Neohaler-Abacavir, Lamivudine and Zidovudine Tablets
- Arcapta Neohaler-Abacavir, lamivudine, and zidovudine
- Arcapta Neohaler-Abaloparatide
- Arcapta Neohaler-Abaloparatide Subcutaneous
- Arcapta Neohaler-Abatacept
- Arcapta Neohaler-Abatacept Auto-Injectors